Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Open Access
- 1 November 1983
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 131 (5) , 2563-2569
- https://doi.org/10.4049/jimmunol.131.5.2563
Abstract
The mechanism of antibody-dependent complement-(C) mediated killing of Escherichia coli 0111B4, strain 12015 (12015), was examined. 12015 was resistant to serum killing when incubated in hypogammaglobulinemic serum (H gamma S) or pooled normal human serum (NHS) that had been previously adsorbed to remove specific antibody (Abs NHS). Presensitization with immune rabbit serum or purified immune rabbit IgG resulted in 1 to 3 log killing when 5 X 10(8) colony forming units (CFU)/ml were incubated in 10 to 40% Abs NHS. Binding of 125I-C3 and 131I-C9 to the bacterial surface of the presensitized and the nonpresensitized strain was quantitated when these organisms were incubated in 10, 20, and 40% Abs NHS. Stable binding of up to 3.0 X 10(5) molecules of C3 and 8.0 X 10(4) molecules of C9 to presensitized and nonpresensitized isolates occurred in the highest concentration of serum, but there was no killing without presensitization. Similar results were found when Abs NHS was chelated with ethylene bis glycoltetraacetic acid containing 2 mM MgCl2 (Mg EGTA) to block classical pathway activation, indicating that antibody mediated the bactericidal reaction through the alternative pathway. Deposition of C3 and C9 and killing of 120 15 in 10% Abs NHS or 10% H gamma S was measured after presensitization with increasing amounts of IgG, F(ab')2, or Fab'. There was a dose-dependent increase in C3 deposition and killing, but only minimal change in C9 binding when 1.0 X 10(3) to 3.2 X 10(4) IgG or F(ab')2/CFU were bound to the bacterial surface. In contrast, there was no increase in C3 or C9 binding and no bacterial killing when 1 X 10(3) to 3.4 X 10(4) molecules Fab'/CFU were bound to the bacterial surface. These experiments show that immune IgG and F(ab')2 can mediate killing of E. Coli 0111B4 by the alternative pathway without changing the extent of terminal C component attachment to the bacterial surface.This publication has 19 references indexed in Scilit:
- Phenotypic and Genetic Variation in the Susceptibility of Haemophilus influenzae Type b to Antibodies to Somatic AntigensJournal of Clinical Investigation, 1980
- Antibody-independent activation of the alternative complement pathway by measles virus-infected cells.Proceedings of the National Academy of Sciences, 1980
- Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.Journal of Clinical Investigation, 1980
- Alternative Complement Pathway-Mediated Lysis of Measles Virus Infected Cells: Induction by IgG Antibody Bound to Individual Viral Glycoproteins and Comparative Efficacy of F(ab′)2 and Fab′ FragmentsThe Journal of Immunology, 1979
- Enhancing Role of IgG in Lysis of Rabbit Erythrocytes by the Alternative Pathway of Human ComplementThe Journal of Immunology, 1979
- Separate Pathways of C Activation by Measles Virus Cytotoxic Antibodies: Subclass Analysis and Capacity of F(ab) Molecules to Activate C via the Alternative PathwayThe Journal of Immunology, 1978
- REQUIREMENT OF SPECIFIC ANTIBODY FOR KILLING OF ESCHERICHIA-COLI BY ALTERNATE COMPLEMENT PATHWAY IN BOVINE SERUM1978
- Characterization of Gonococcal Antigens Responsible for Induction of Bactericidal Antibody in Disseminated InfectionJournal of Clinical Investigation, 1977
- Variability of the Lytic Susceptibility of Neisseria Gonorrhoeae to Human SeraThe Journal of Immunology, 1977
- Activation of the Classical and Properdin Pathways of Complement by Bacterial Lipopolysaccharides (LPS)The Journal of Immunology, 1977